TickerFacts.

Omeros Corp (OMER): Share Repurchases

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$9.88M
Trailing 12 months to 2026-06-30
$11.85M2021-12-31: $02022-12-31: $02023-12-31: $4.65M2024-12-31: $11.85M2025-12-31: $0$0
2021-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$0-100.0%2026-03-31, From 2025-01-01
2024-12-31$11.85M+154.6%2026-03-31, From 2024-01-01
2023-12-31$4.65Mn/a2026-03-31, From 2023-01-01
2022-12-31$0n/a2025-03-31, From 2022-01-01
2021-12-31$0n/a2024-04-01, From 2021-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Omeros Corp (OMER)2025-12-31$0-100.0%
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31$25.52Mn/a
Keros Therapeutics, Inc. (KROS)2025-12-31$375.00Mn/a
Zymeworks Inc. (ZYME)2025-12-31$41.70M+38.7%
Anaptysbio, Inc (ANAB)2025-12-31$68.63Mn/m
Zentalis Pharmaceuticals, Inc. (ZNTL)2025-12-31$9.98Mn/a
Zevra Therapeutics, Inc. (ZVRA)2024-12-31$0-100.0%
Nektar Therapeutics (NKTR)2025-12-31$0-100.0%
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.76Mn/a

Compare OMER, AVIR, KROS, ZYME side by side · Screen every company in Pharmaceutical Preparations ↗